Abstract:PRKAG2 gene encodes the γ2 regulatory subunit of AMP-activated protein kinase (AMPK) that acts as a sensor of cellular energy status, and its germline mutations are responsible for PRKAG2 cardiac syndrome (PCS). The majority of missense mutations of cystathionine beta-synthase (CBS) domains found in PCS impair the binding activity of PRKAG2 to adenosine derivatives, and therefore lead to PRKAG2 function impairment and AMPK activity alteration, resulting in a familial syndrome of ventricular preexcitation, conduction defects, and cardiac hypertrophy. However, it is unclear about the PRKAG2 mutation in the non-CBS domain. Here, a Chinese family exhibiting the cardiac syndrome associated with a novel heterozygous PRKAG2 mutation (Gly100Ser) mapped to exon 3 encoding a non-CBS domain is described and the function of this novel mutation was investigated in vitro.The PRKAG2 G100S and R302Q mutations were constructed by a two-step polymerase chain reaction and then transfected into CCL13 cells by lentivirus vectors. Wild-type PRKAG2 gene transfection was used as a negative control. PRKAG2 expression was determined by Western blot. Immunofluorescence was used to localize the intracellular PRKAG2 proteins. MTT assay was performed to explore the effect of mutations on cell proliferation. Periodic acid-Schiff staining was used for detecting glycogen accumulation. AMPK concentration was measured with enzyme-linked immunosorbent assay.Our results showed neither intracellular localization of PRKAG2 nor cell growth was altered. In contrast, PRKAG2 protein expression levels were significantly reduced by this mutation. Furthermore, PRKAG2-mediated activity of AMPK was attenuated, resulting in glycogen metabolism dysregulation. These findings revealed that non-CBS domains of PRKAG2 were essential to the regulation of AMPK activity, similar to CBS.Our study ascribes a crucial regulatory role to the novel PRKAG2 G100S mutation, and reiterates that PCS occurs as a consequence of AMPK signaling abnormality caused by PRKAG2 gene mutations.

Molecular Cloning, Genomic Organization, and Mapping of PRKAG2, a Heart Abundant Γ2 Subunit of 5′-Amp-activated Protein Kinase, to Human Chromosome 7Q36

Cloning, Tissue Expression Pattern, And Chromosome Localization Of Human Protein Kinase B Gamma Gene

Cloning, tissue expression pattern, and chromosome localization of human protein kinase Bγ gene

Cloning, expression and genomic structure of a novel human GNB2L1 gene, which encodes a receptor of activated protein kinase C (RACK) *

Molecular Cloning and Mapping of the Brain-Abundant B1γ Subunit of Protein Phosphatase 2A, PPP2R2C, to Human Chromosome 4P16

Cloning and Mapping of Human PKIB and PKIG, and Comparison of Tissue Expression Patterns of Three Members of the Protein Kinase Inhibitor Family, Including PKIA.

Cloning, Characterization, and Chromosome Mapping of RPS6KC1, a Novel Putative Member of the Ribosome Protein S6 Kinase Family, to Chromosome 12Q12–q13.1

Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway

Cloning and Mapping of A Novel Human Serum/Glucocorticoid Regulated Kinase-Like Gene, Sgkl, to Chromosome 8Q12.3-Q13.1

Identification of Alternative Splicing Variants of the Beta Subunit of Human Ca(2+)/calmodulin-dependent Protein Kinase II with Different Activities.

Sequence Analysis and Characterization of a Novel cDNA Clone

[Cloning and Tissue Expressive Pattern Analysis of the Human Ribosomal S6 Kinase-Rps6ka5 Cdna].

Human γ2-AMPK Mutations

Molecular cloning and characterization of a novel human gene containing 4 ankyrin repeat domains.

[Cloning, Expression, Distribution and Subcellular Localization of AK078438 Gene].

Cloning, Characterization and Expression of CDK5RAP1_v3 and CDK5RAP1_v4, Two Novel Splice Variants of Human CDK5RAP1.

Molecular Cloning and Localization of Human Ataxin2-Like Gene

Cloning, Characterization and Mapping of the Human ATP5E Gene, Identification of Pseudogene ATP5EP1, and Definition of the ATP5E Motif

Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease

Same AMPKγ2 R302Q Mutation Encoded by PRKAG2 Defection Result in Different Phenotypes in Two Brother Cases

Cloning And Analysis Of Human Apg16l